Dr Christine Shu Mei Lee

Research Fellow
  • LEE, CSM, Clarke , L, Kershaw, G et al. 2023, 'Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms', Research and Practice in Thrombosis and Haemostasis, vol. 7, no. 3.
  • LEE, C, Kershaw, G, Favaloro, E et al. 2018, 'Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin‐induced thrombocytopenia', Journal of Thrombosis and Haemostasis, vol. 20, no. 4, pp. 975-988.
  • Clarke , L, Brighton, T, Chunilal, S et al. 2023, 'Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem', Vaccine, vol. 41, no. 20, pp. 3285-3291.
  • Montague PhD, S, Hicks, S, Lee, CSM et al. 2020, 'Fibrin exposure triggers αIIbβ3-independent platelet aggregate formation, ADAM10 activity and glycoprotein VI shedding in a charge-dependent manner', Journal of Thrombosis and Haemostasis, vol. 18, no. 6, pp. 1447-1458.
  • Hicks, S, Lee, C, Ali, S et al. 2020, 'The molecular basis of immune-based platelet disorders', Clinical Science, vol. 134, no. 21, pp. 2807-2822.
  • Rabbolini, D, Gardiner, E, Morel-Kopp, M et al 2017, 'Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?', Research and Practice in Thrombosis and Haemostasis, vol. 1, no. 2, pp. 291-295.
  • Montague, SJ, Lee, CSM, Lee, W et al. 2018, 'Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI', Blood Advances, vol. 2, no. 3, pp. 240-251pp.